{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:14:23Z","timestamp":1740460463961,"version":"3.37.3"},"reference-count":24,"publisher":"European Respiratory Society (ERS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2002,12,20]]},"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:p>Adherence to antituberculosis treatment, a major determinant of outcome, is of special concern in human immunodeficiency virus (HIV)\u2010positive patients. However, tuberculosis death in HIV\u2010positive patients remains higher than in HIV\u2010negative patients, regardless of adherence.<\/jats:p><jats:p>To assess determinants for an unfavourable tuberculosis outcome (defined as no cure or death), and determinants for nonadherence to antituberculosis treatment, 70 HIV\u2010positive patients with tuberculosis referred to an outpatient centre were studied. Patient outcome was compared according to HIV risk factors, other opportunistic diseases, antiretroviral drugs use, current<jats:italic>i.v.<\/jats:italic>drugs use, a methadone programme participation, tuberculosis features, treatment characteristics and adherence. Adherent and nonadherent patient characteristics were also compared.<\/jats:p><jats:p>An unfavourable outcome occurred in 22.9% of patients and 32.9% were nonadherent with therapy. Nonadherence was the only independent determinant for an unfavourable outcome. Adherence was independently associated with current<jats:italic>i.v.<\/jats:italic>drug use, treatment complications and use of methadone.<\/jats:p><jats:p>This study confirms that human immunodeficiency virus-infected patients, treated as outpatients, have high rates of nonadherence and that adherence is the strongest determinant for tuberculosis outcome. Independently of the current use of drugs, a methadone programme improves adherence to treatment.<\/jats:p>","DOI":"10.1183\/09031936.03.00077302","type":"journal-article","created":{"date-parts":[[2003,5,2]],"date-time":"2003-05-02T21:35:02Z","timestamp":1051911302000},"page":"785-788","source":"Crossref","is-referenced-by-count":15,"title":["The role of adherence in tuberculosis HIV\u2010positive patients treated in ambulatory regimen"],"prefix":"10.1183","volume":"21","author":[{"given":"M.","family":"Rocha","sequence":"first","affiliation":[]},{"given":"S.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"L.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"H.","family":"Barros","sequence":"additional","affiliation":[]}],"member":"81","published-online":{"date-parts":[[2003,5,1]]},"reference":[{"key":"2024101810143519000_21.5.785.1","unstructured":"Grange JM. Epidemiology and control of mycobacterial disease In:. Mycobacteria and Human Disease. 2nd ednOxford, Oxford University Press, 1996; pp.\u2005117\u2013137."},{"key":"2024101810143519000_21.5.785.2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0962-8479(96)90096-9","volume":"77","year":"1996","journal-title":"Tuber Lung Dis"},{"key":"2024101810143519000_21.5.785.3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0962-8479(05)80024-3","volume":"76","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"2024101810143519000_21.5.785.4","first-page":"1014","volume":"41","year":"1995","journal-title":"Can Fam Physician"},{"key":"2024101810143519000_21.5.785.5","first-page":"1030","volume":"41","year":"1995","journal-title":"Can Fam Physician"},{"key":"2024101810143519000_21.5.785.6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.1994.03520070055038","volume":"272","year":"1994","journal-title":"JAMA"},{"key":"2024101810143519000_21.5.785.7","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Core Curriculum on Tuberculosis. What the clinician should know. 4th EdnAtlanta, GA, USA, 2000."},{"key":"2024101810143519000_21.5.785.8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003495-199958040-00005","volume":"58","year":"1999","journal-title":"Drugs"},{"key":"2024101810143519000_21.5.785.9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00063198-199605000-00013","volume":"2","year":"1996","journal-title":"Curr Opin Pulm Med"},{"key":"2024101810143519000_21.5.785.10","first-page":"93","volume":"15","year":"1996","journal-title":"J Addict Dis"},{"key":"2024101810143519000_21.5.785.11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"key":"2024101810143519000_21.5.785.12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9343(96)00402-0","volume":"102","year":"1997","journal-title":"Am J Med"},{"key":"2024101810143519000_21.5.785.13","first-page":"134","volume":"2","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024101810143519000_21.5.785.14","first-page":"44","volume":"2","year":"1998","journal-title":"Inter J Tuberc Lung Dis"},{"key":"2024101810143519000_21.5.785.15","first-page":"816","volume":"11","year":"1996","journal-title":"Eur Respir J"},{"key":"2024101810143519000_21.5.785.16","first-page":"246","volume":"1","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024101810143519000_21.5.785.17","unstructured":"The Computerized Information System for Infectious Diseases. World Health Organization Regional Office for Europe. Number of tuberculosis cases notifiedhttp:\/\/www.cisid.who.dk\/tb\/TBProfile.asp. Accessed and last updated November 11, 2002."},{"key":"2024101810143519000_21.5.785.18","unstructured":"National Institute of Health. AIDS: The Portuguese situation \u2013 June 1998Lisboa, Portugal, National Institute of Health, 1998;. pp.\u20055\u20137."},{"key":"2024101810143519000_21.5.785.19","unstructured":"National Institute of Statistics (INE). Estat\u00edsticas da Sa\u00fade 1994Lisboa. Portugal, National Institute of Statistics, 1995;. p. 180."},{"key":"2024101810143519000_21.5.785.20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00002030-199802000-00009","volume":"12","year":"1998","journal-title":"AIDS"},{"key":"2024101810143519000_21.5.785.21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMcp013579","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"2024101810143519000_21.5.785.22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","volume":"281","year":"1999","journal-title":"JAMA"},{"key":"2024101810143519000_21.5.785.23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJM199902043400506","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"key":"2024101810143519000_21.5.785.24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM199902043400512","volume":"340","year":"1999","journal-title":"N Engl J Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.03.00077302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:18:03Z","timestamp":1740377883000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.03.00077302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2003,5,1]]},"published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1183\/09031936.03.00077302"],"URL":"https:\/\/doi.org\/10.1183\/09031936.03.00077302","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}